Home> Products> sustained release progesterone medication india

{ "products": [ { "_id": "693c0c9c0c30ac5c9f8203b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide Mononitrate IP 30mg Tablets", "description": "CARDULES ISMN SR 30 tablets provide sustained-release Isosorbide Mononitrate IP 30mg, a nitrate medication designed for long-term management of angina in patients with coronary artery disease. This formulation from Steris Healthcare Pvt Ltd ensures steady vasodilation to improve heart blood flow and reduce chest pain episodes. It supports daily activities by minimizing oxygen demand on the heart muscle.​\nProduct Overview\nCARDULES ISMN SR 30 contains Isosorbide Mononitrate IP 30mg in a sustained-release matrix, allowing once-daily dosing for consistent therapeutic levels over 12-24 hours. The tablet's extended-release technology prevents peak-trough fluctuations common in immediate-release forms, promoting better patient compliance. Each film-coated tablet delivers precise bioavailability, with the active metabolite nitric oxide activating guanylate cyclase to boost cyclic GMP, relaxing vascular smooth muscle primarily in veins.​\n\nThis mechanism reduces preload (venous return to the heart) and afterload (arterial resistance), easing cardiac workload without significantly affecting heart rate. Unlike short-acting nitrates for acute relief, CARDULES ISMN SR 30 targets prophylaxis in chronic stable angina, often prescribed alongside beta-blockers or calcium channel blockers. Available in strips of 10 tablets, it undergoes rigorous quality testing at Steris facilities to meet IP standards, ensuring purity and stability.​\n\nKey Uses\nCARDULES ISMN SR 30 primarily prevents angina pectoris in coronary artery disease, where narrowed vessels limit oxygen supply during exertion. Patients experience fewer chest pain attacks during walking, climbing stairs, or stress.​\n\nIt manages chronic stable angina by enhancing myocardial perfusion, suitable for long-term therapy in adults over 18. Healthcare providers may use it adjunctively for coronary spasm or post-myocardial infarction prophylaxis to stabilize symptoms.​\n\nIn select cases, it aids heart failure management by offloading the heart, though not as monotherapy. Always initiate under cardiology supervision with dose titration to tolerance.​\n\nMajor Benefits\nThe sustained-release profile offers 24-hour protection with single morning dosing, improving adherence and lifestyle quality for active patients. It boosts exercise tolerance by 20-30% in trials, allowing longer physical efforts without angina onset.​\n\nBy dilating vessels, it decreases ischemia risk, potentially lowering hospitalization rates for acute episodes. Compared to placebo, users report halved attack frequency within weeks, enhancing daily productivity and emotional well-being.​\n\nBenefit\tMechanism\tPatient Outcome\nAngina Prevention\tVasodilation reduces preload/afterload ​\tFewer attacks, better exertion capacity\nSteady Relief\tSR formulation maintains levels ​\tOnce-daily convenience, no fluctuations\nHeart Protection\tImproves O2 delivery ​\tReduced ischemia, enhanced QoL\nCompliance Boost\tSimple regimen ​\tHigher adherence vs multiple doses\nAdditional perks include minimal impact on blood pressure in normotensives and compatibility with anti-anginals, making it versatile in combo therapy.\n\nPotential Side Effects\nCommon effects include headache (dose-related, often transient in first week), dizziness, or flushing due to vasodilation—hydrate and rise slowly to manage. Gastrointestinal upset like nausea occurs in 5-10% initially.​\n\nOrthostatic hypotension risks fainting, especially early; avoid alcohol or other vasodilators. Rare serious issues encompass severe hypotension, tachycardia, or methemoglobinemia with overdose—monitor blood pressure regularly.​\n\nAllergic reactions (rash, itching) or vision changes warrant discontinuation. Contraindicated in hypotension, glaucoma, or recent PDE5 inhibitor use; caution in anemia or hypothyroidism.​\n\nDosage Guidelines\nStart with 30mg once daily upon waking, swallowed whole without crushing. Titrate to 60mg if tolerated after 3-7 days, max 120mg/day. Take on empty stomach for optimal absorption; avoid late dosing to prevent nocturnal headaches.​\n\nAdjust for elderly or renal/hepatic impairment. Tolerance may develop—nitrate-free interval (evening) helps sustain efficacy. Store below 30°C.​\nConclusion\nCARDULES ISMN SR 30 empowers angina patients with reliable, once-daily prevention, restoring confidence in routine activities under Steris Healthcare's quality assurance. Its targeted vasodilation balances efficacy and tolerability for sustained heart health", "price": 65.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2243, "imageuri": "https://productimages.withfloats.com/actual/693c0ca6391a3fa44b0608d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0ca6391a3fa44b0608d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:37:48.92Z", "updatedon": "2025-12-12T12:37:48.92Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-ip-30mg-tablets/2243", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 30", "category": "", "tags": [ "Isosorbide Mononitrate IP 30mg Tablets", "coronary artery disease", "heart blood flow and reduce chest pain episodes", "oxygen demand on the heart muscle", "relaxing vascular smooth muscle primarily in veins" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937d6192800555f6696845e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Naltrexone Hydrochloride IP 50 mg", "description": "Naltrexone Hydrochloride IP 50 mg, marketed under the brand name NALTREXON 50, is a prescription medication primarily used in the management of opioid and alcohol dependence. This potent pharmaceutical agent plays a crucial role in addiction treatment programs by helping individuals reduce or eliminate their reliance on addictive substances. Below is an in-depth description of the product, its uses, key benefits, possible side effects, and a concluding overview.\n\nProduct Description\nNALTREXON 50 contains Naltrexone Hydrochloride as its active ingredient, formulated as an immediate-release tablet with a strength of 50 mg per tablet. Naltrexone is an opioid antagonist, meaning it works by blocking the opioid receptors in the brain. By binding to these receptors without activating them, Naltrexone prevents opioids from producing their euphoric and sedative effects, which are often responsible for addiction.\nPharmacologically, Naltrexone Hydrochloride belongs to the class of medications known as opioid antagonists, specifically targeting mu, kappa, and delta opioid receptors. Its chemical composition and formulation comply with the Indian Pharmacopoeia (IP) standards, ensuring high quality and purity that meet regulatory guidelines.\n\nNALTREXON 50 is indicated for adults who are already detoxified from opioids or alcohol and are motivated to maintain abstinence from these substances. It supports addiction recovery by reducing cravings and diminishing the rewarding effects if relapse occurs.\n\nUses of NALTREXONE 50\nNALTREXONE 50 is primarily prescribed for two major therapeutic purposes:\n\nAlcohol dependence management: It helps reduce the desire to consume alcohol and lowers the risk of relapse by blocking alcohol’s rewarding effects in the brain.\n\nOpioid dependence treatment: Naltrexone aids in preventing relapse by blocking the euphoric and sedative effects induced by opioid drugs like heroin, morphine, and prescription painkillers.\n\nThe medication is typically administered as part of a comprehensive addiction treatment plan that includes counseling, behavioral therapies, and support groups. It is essential that the patient is opioid-free for at least 7 to 10 days before starting Naltrexone to avoid precipitating withdrawal symptoms.\n\nKey Benefits\nReduces cravings and relapse: By blocking opioid receptors, NALTREXON 50 reduces cravings and diminishes the pleasure derived from alcohol or opioid consumption, which helps patients stay abstinent.\n\nNon-addictive: Unlike some addiction treatments that contain opioids, Naltrexone is non-addictive and does not produce tolerance or dependence.\n\nSupports long-term recovery: When combined with behavioral therapy, Naltrexone enhances the likelihood of successful long-term abstinence from alcohol and opioids.\n\nImproves quality of life: Patients taking NALTREXONE 50 often experience improved emotional stability, better social functioning, and enhanced physical health compared to ongoing substance use.\n\nOral administration: As an oral tablet, Naltrexone is easy to administer, improving patient compliance.\n\nReduces overdose risk: By blocking the euphoric effects of opioids, it reduces the temptation to use high doses, thereby decreasing the risk of overdose.\n\nSide Effects\nLike all medications, NALTREXON 50 can cause side effects, although not everyone experiences them. Common side effects associated with Naltrexone Hydrochloride include:\n\nNausea and vomiting: These digestive issues are most frequent during the initial treatment phase but often subside with continued use.\n\nHeadache: Mild to moderate headaches may occur.\n\nDizziness and fatigue: Some patients report feeling dizzy or tired, particularly in the beginning.\n\nInsomnia: Difficulty sleeping or altered sleep patterns may be experienced.\n\nAnxiety or nervousness: Some individuals may feel anxious or agitated.\n\nJoint or muscle pain: Muscle aches and joint discomfort can occasionally occur.\n\nLiver function changes: Very rarely, Naltrexone may lead to elevations in liver enzymes; therefore, monitoring liver function tests during treatment is recommended.\n\nSevere side effects or allergic reactions are uncommon but require immediate medical attention. These include symptoms such as rash, swelling, difficulty breathing, or severe abdominal pain.\n\nIt is crucial for patients to inform their healthcare provider about any pre-existing liver conditions, prescribed or over-the-counter medications, and any history of opioid- or alcohol-related health issues before starting therapy.\n\nConclusion\nNALTREXON 50, containing Naltrexone Hydrochloride IP 50 mg, is a highly effective medication designed to aid in the treatment of alcohol and opioid dependence. Its action as an opioid antagonist helps block the pleasurable effects of these substances, reduce cravings, and diminish relapse risks. When used responsibly as part of a multidisciplinary treatment approach that incorporates counseling and behavioral therapies, NALTREXON 50 significantly enhances the chances of sustained recovery and improved quality of life.\n\nThough generally well-tolerated, users should be aware of potential side effects and consult healthcare providers regularly to ensure safety throughout the course of treatment. With careful medical oversight and patient commitment, NALTREXON 50 is a valuable tool in the fight against substance dependence, offering hope for individuals seeking freedom from addiction.", "price": 745.0, "discountamount": 223.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2240, "imageuri": "https://productimages.withfloats.com/actual/6937d61c3811575f667dea96.png", "tileimageuri": "https://productimages.withfloats.com/tile/6937d61c3811575f667dea96.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T07:56:09.144Z", "updatedon": "2025-12-09T07:56:09.144Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/naltrexone-hydrochloride-ip-50-mg/2240", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NALTREXON 50", "category": "NEUROLOGY RANGE", "tags": [ "Naltrexone Hydrochloride IP 50 mg", "alcohol dependence", "opioid antagonist", "Naltrexone is easy to administer", "opioid- or alcohol-related health issues", "NALTREXONE 50" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "690b41bfb84ade1a1a5cf07f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tiotropium Bromide and Formoterol Fumarate Inhaler", "description": "Tiotropium Bromide and Formoterol Fumarate Inhaler is a combination medication designed to provide long-term relief for patients suffering from chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This inhaler combines the bronchodilator properties of tiotropium bromide with the fast-acting benefits of formoterol fumarate, ensuring both immediate and sustained relief from breathing difficulties. By improving airflow in the lungs, this inhaler significantly enhances the quality of life for individuals with obstructive airway diseases.\n\nComposition and Mechanism of Action\nThe inhaler contains two active ingredients:\n\nTiotropium Bromide – a long-acting anticholinergic agent that relaxes the muscles around the airways, preventing bronchospasm and helping to keep the airways open for an extended period.\n\nFormoterol Fumarate – a long-acting beta-2 adrenergic agonist (LABA) that quickly relaxes airway muscles, providing fast relief from shortness of breath and wheezing.\n\nTogether, these agents work synergistically. Tiotropium ensures long-term bronchodilation, while formoterol provides rapid symptom relief, making this inhaler ideal for patients who require both immediate and sustained respiratory support.\n\nUses\nThe Tiotropium Bromide and Formoterol Fumarate Inhaler is primarily used to:\n\nManage Chronic Obstructive Pulmonary Disease (COPD) – Helps reduce the frequency and severity of COPD exacerbations, improving breathing efficiency.\n\nControl Asthma Symptoms – Offers better control of persistent asthma symptoms, particularly in patients who do not respond adequately to standard inhalers.\n\nPrevent Exercise-Induced Bronchospasm – Can be used as part of a preventive regimen for patients prone to exercise-triggered breathing difficulties.\n\nEnhance Overall Lung Function – Improves airflow and oxygen exchange, contributing to better overall respiratory health.\n\nDosage and Administration\nProper usage of the inhaler is critical for maximum effectiveness. The dosage may vary based on your condition and doctor's recommendation. General guidelines include:\n\nTypically, one inhalation twice daily (morning and evening).\n\nShake the inhaler well before each use.\n\nExhale fully, place the mouthpiece in your mouth, and inhale deeply while pressing the inhaler to release the medication.\n\nHold your breath for 10 seconds after inhalation to ensure the medication reaches deep into the lungs.\n\nRinse your mouth with water after use to reduce the risk of oral infections or irritation.\n\nPatients should strictly follow their doctor’s instructions regarding dosage, frequency, and technique, as incorrect use may reduce the medication’s effectiveness.\n\nKey Benefits\n\nDual Action for Immediate and Long-Term Relief – Combines a fast-acting bronchodilator with a long-acting maintenance agent.\n\nReduces Exacerbations – Regular use can significantly lower the risk of flare-ups and hospital visits for COPD or severe asthma patients.\n\nImproves Lung Function – Enhances airflow and oxygen intake, leading to reduced shortness of breath and wheezing.\n\nConvenient Usage – A single inhaler provides both maintenance and symptom relief, reducing the need for multiple medications.\n\nEnhanced Quality of Life – Patients often experience better sleep, increased physical activity tolerance, and improved daily functioning.\n\nSide Effects\nWhile Tiotropium Bromide and Formoterol Fumarate Inhaler is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nDry mouth or throat irritation\n\nCough or hoarseness\n\nHeadache or dizziness\n\nTremors or mild palpitations\n\nSerious but rare side effects may include:\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nIrregular heartbeat or chest pain\n\nWorsening of respiratory symptoms\n\nPatients should immediately consult a healthcare professional if they experience severe or persistent side effects. Regular follow-up with a doctor is recommended to monitor lung function and adjust the dosage if necessary.\n\nPrecautions\n\nNot recommended for individuals with hypersensitivity to either tiotropium bromide or formoterol fumarate.\n\nShould be used cautiously in patients with cardiovascular diseases, kidney or liver problems, or thyroid disorders.\n\nAvoid sudden discontinuation without consulting your doctor, as this may worsen symptoms.\n\nAlways carry a rescue inhaler for emergency situations, as this inhaler is primarily for maintenance and not for immediate acute attacks.\n\nPrice\nThe price of Tiotropium Bromide and Formoterol Fumarate Inhaler may vary depending on the brand, pack size, and pharmacy. It is advisable to compare prices and check with local pharmacies for the most cost-effective options. Many insurance plans may cover this inhaler under prescription respiratory medications.\n\nConclusion\nTiotropium Bromide and Formoterol Fumarate Inhaler is a highly effective combination treatment for patients suffering from COPD and asthma. By providing both rapid symptom relief and long-term airway maintenance, it helps patients breathe more easily, reduces the frequency of exacerbations, and improves overall quality of life. Proper usage, adherence to prescribed dosage, and monitoring for side effects are essential for achieving the best results. For anyone managing chronic respiratory conditions, this inhaler represents a reliable and convenient treatment option under medical guidance.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2196, "imageuri": "https://productimages.withfloats.com/actual/690b41c1d25e5639c9089541.png", "tileimageuri": "https://productimages.withfloats.com/tile/690b41c1d25e5639c9089541.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-05T12:23:27.485Z", "updatedon": "2025-12-09T06:10:21.438Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tiotropium-bromide-and-formoterol-fumarate-inhaler/2196", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TIOTROPIN F", "category": "ASTHMA RANGE", "tags": [ "Tiotropium Bromide and Formoterol Fumarate Inhaler", "Chronic Obstructive Pulmonary Disease (COPD) and asthma.", "Chronic Obstructive Pulmonary Disease (COPD) and asthma" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6905fe704704b5ad3ff33652", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Salmeterol and Fluticasone Propionate Inhalation IP ", "description": "Salmeterol and Fluticasone Propionate Inhalation IP is a combination medication widely used for the management and long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). This dual-acting inhalation therapy combines two powerful active ingredients — Salmeterol, a long-acting bronchodilator, and Fluticasone Propionate, a corticosteroid. Together, they work synergistically to ease breathing difficulties, control inflammation, and prevent respiratory flare-ups.\n\nIn India, respiratory diseases such as asthma and COPD affect millions of people, especially due to pollution, smoking, and changing environmental conditions. For these individuals, Salmeterol and Fluticasone Propionate Inhalation IP serves as a cornerstone therapy that offers reliable control of symptoms and improves overall lung function.\n\nComposition and Mechanism of Action\n\nThis inhalation medication contains:\n\nSalmeterol (50 mcg) – a long-acting β₂-adrenergic receptor agonist (LABA) that relaxes airway muscles, allowing air to flow more freely into the lungs.\n\nFluticasone Propionate (250 mcg or 500 mcg) – a potent corticosteroid that helps reduce inflammation, swelling, and mucus production in the airways.\n\nWhen inhaled, Salmeterol provides prolonged bronchodilation, maintaining open airways for up to 12 hours, while Fluticasone acts directly on lung tissues to minimize inflammatory responses. This dual mechanism ensures both immediate relief and long-term control of respiratory symptoms.\n\nUses of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Asthma\n\nThis combination is one of the most prescribed maintenance therapies for asthma management. It helps reduce the frequency and severity of asthma attacks, improves breathing capacity, and enables patients to lead a more active lifestyle.\n\n2. Chronic Obstructive Pulmonary Disease (COPD)\n\nIt is also indicated for COPD, including chronic bronchitis and emphysema. In these conditions, it helps relieve breathlessness, persistent cough, and wheezing, thereby improving lung efficiency and quality of life.\n\n3. Prevention of Asthma Exacerbations\n\nRegular use of this inhalation helps prevent sudden asthma flare-ups triggered by allergens, cold weather, or exercise.\n\n4. Improvement of Lung Function\n\nBy consistently controlling inflammation and relaxing airway muscles, the medication enhances FEV₁ (Forced Expiratory Volume), a measure of how efficiently a patient can exhale.\n\nKey Benefits of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Dual Therapeutic Action\n\nThe combination of a bronchodilator (Salmeterol) and an anti-inflammatory (Fluticasone) provides comprehensive control over both the causes and symptoms of respiratory conditions.\n\n2. Long-Lasting Relief\n\nWith its long-acting formulation, patients experience up to 12 hours of relief, reducing the need for frequent dosing and ensuring steady symptom control throughout the day or night.\n3. Prevention of Asthma and COPD Attacks\nRegular use helps minimize acute exacerbations, reducing hospital visits, emergency interventions, and dependency on quick-relief inhalers.\n4. Improved Breathing Comfort\n\nBy opening up constricted airways and controlling inflammation, it allows for easier breathing, better oxygen exchange, and improved stamina in daily activities.\n5. Enhanced Quality of Life\nPatients on regular inhalation therapy report fewer night-time symptoms, improved sleep, and better physical endurance, allowing them to enjoy an active, productive life.\n6. Targeted Lung Delivery\n\nAs an inhalation-based therapy, it directly delivers medication to the lungs where it’s most needed, minimizing systemic exposure and potential side effects.\n\nHow to Use\n\nShake the inhaler well before use to ensure even distribution of medicine.\n\nExhale fully and then inhale deeply through the mouthpiece while pressing down the canister to release one dose.\n\nHold your breath for a few seconds to allow the medicine to reach deep into the lungs.\n\nRinse your mouth after use to reduce the risk of fungal infections like oral thrush.\n\nPatients are advised to use the inhaler regularly at the same time each day for best results. It is not meant for sudden asthma attacks — a separate rescue inhaler should be kept for emergency relief.\n\nPossible Side Effects\n\nLike any medication, Salmeterol and Fluticasone Propionate Inhalation IP may cause mild to moderate side effects, though not everyone experiences them. Common side effects include:\n\n1. Oral and Throat Irritation\n\nDryness, irritation, or hoarseness of the throat may occur. Rinsing the mouth after use helps minimize this.\n\n2. Oral Thrush (Candidiasis)\n\nProlonged corticosteroid use can increase the risk of fungal infections in the mouth. Maintaining oral hygiene is essential.\n\n3. Headache or Dizziness\n\nSome users may experience mild headaches or lightheadedness, which typically subside over time.\n\n4. Muscle or Joint Pain\n\nOccasional mild muscle cramps or joint discomfort may occur, especially in long-term use.\n\n5. Palpitations or Tremors\n\nIn rare cases, Salmeterol may cause a slight increase in heart rate or mild tremors, particularly when the dose is higher than recommended.\n\n6. Cough or Respiratory Discomfort\n\nMild coughing or a temporary feeling of breath tightness may occur immediately after inhalation but usually passes quickly.\n\nIf any side effects persist or worsen, it is advisable to consult a healthcare professional immediately.\n\nPrecautions and Warnings\n\nNot for sudden asthma attacks — this inhaler should be used only for maintenance therapy.\n\nPregnant or breastfeeding women should use it only after medical advice.\n\nDo not exceed the prescribed dose as overuse may increase the risk of cardiovascular side effects.\n\nPatients with heart disease, hypertension, or diabetes should inform their doctor before starting treatment.\n\nAlways store the inhaler in a cool, dry place, away from direct sunlight and moisture.\n\nConclusion\n\nSalmeterol and Fluticasone Propionate Inhalation IP is a clinically proven, reliable treatment option for individuals suffering from chronic respiratory conditions like asthma and COPD. By combining the bronchodilatory power of Salmeterol with the anti-inflammatory efficacy of Fluticasone Propionate, it delivers long-term symptom control, improves lung function, and enhances quality of life.\n\nWhen used consistently and correctly under medical supervision, this inhalation therapy not only helps manage respiratory symptoms but also reduces the frequency of exacerbations and hospitalizations. For patients seeking dependable relief and sustained respiratory health, Salmeterol and Fluticasone Propionate Inhalation IP remains one of the most trusted and effective therapies available today.", "price": 442.0, "discountamount": 132.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2194, "imageuri": "https://productimages.withfloats.com/actual/6905fe746e096b327485136e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6905fe746e096b327485136e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-01T12:34:56.205Z", "updatedon": "2025-12-09T06:11:14.949Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/salmeterol-and-fluticasone-propionate-inhalation-ip-/2194", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "AIRFLOW 50 INH", "category": "ASTHMA RANGE", "tags": [ "Salmeterol and Fluticasone Propionate Inhalation IP", "asthma and chronic obstructive pulmonary disease (COPD)", "Fluticasone Propionate", "air to flow" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2025-12-09T06:06:38.819Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-12-02T06:31:16.051Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin and Linagliptin Tablets", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 324.0, "discountamount": 97.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-12-09T06:36:10.392Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-and-linagliptin-tablets/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH LINA 25/5", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets", "help manage blood sugar levels", "2 diabetes mellitus", "Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2)" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6880c5c93213965b404bd37e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLO THEO TABLETS", "description": "SLO THEO Tablets is a combination respiratory medication containing Etophylline 231 mg and Theophylline 69 mg, specially formulated to provide effective and long-lasting relief from bronchospasm associated with asthma, bronchitis, and chronic obstructive pulmonary diseases (COPD). These tablets belong to the class of bronchodilators, which work by relaxing the muscles in the lungs and widening the airways to make breathing easier.\n\nTheophylline+etofylline contains two bronchodilators namely, Theophylline and Etofylline, used to treat symptoms of asthma and chronic obstructive pulmonary diseases (COPD).\n\nWhat is SLO THEO Tablet?\nSLO THEO Tablet is a prescription drug that combines etophylline and theophylline in a sustained-release form, helping to manage and control chronic breathing conditions. Etophylline enhances the solubility and bioavailability of theophylline, thereby improving therapeutic outcomes in patients with obstructive airway diseases.\n\nIt is particularly useful in patients who suffer from repeated asthma attacks or have difficulty breathing due to COPD. The medication is typically taken orally, and its slow-release mechanism ensures consistent bronchodilation over several hours.\n\nUses of Etophylline and Theophylline Tablets\nSLO THEO Tablets are primarily used for the prevention and treatment of:\n\nBronchial asthma\n\nChronic bronchitis\n\nEmphysema\n\nWheezing and shortness of breath\n\nChronic obstructive pulmonary disease (COPD)\n\nRespiratory distress due to airway narrowing\n\nBy relaxing the smooth muscles in the bronchial tubes, etophylline and theophylline tablets help in clearing air passages and improving airflow, thus reducing breathing effort and improving quality of life.\n\nSide Effects of SLO THEO Tablets\nWhile SLO THEO Tablets are generally well-tolerated, some individuals may experience certain side effects, especially when starting treatment or at higher doses:\n\nNausea and vomiting\n\nHeadache\n\nInsomnia or restlessness\n\nIncreased heartbeat (palpitations)\n\nDizziness or tremors\n\nStomach discomfort\n\nMuscle cramps\n\nIrritability or anxiety\n\nIf any of these symptoms persist or worsen, consult your doctor promptly. Serious allergic reactions are rare but require immediate medical attention.\n\nPrecautions Before Using SLO THEO Tablets\nBefore starting therapy with etophylline and theophylline tablets, discuss the following with your healthcare provider:\n\nInform if you have a history of heart disease, liver disorders, epilepsy, stomach ulcers, hyperthyroidism, or high blood pressure.\n\nUse with caution in elderly patients and those with weakened liver function.\n\nAvoid excessive consumption of caffeine-containing products (like coffee, tea, or energy drinks), as they may increase side effects.\n\nNot recommended for use during pregnancy or breastfeeding unless prescribed by a healthcare professional.\n\nDo not stop the medication suddenly without medical advice.\n\nDrug Interactions\nSLO THEO Tablets may interact with several other drugs, potentially affecting how either medicine works or increasing the risk of side effects. Always inform your doctor about all the medications and supplements you are taking.\n\nWhat drugs interact with etophylline and theophylline tablets?\n\nAntibiotics like ciprofloxacin, erythromycin\n\nAnti-seizure medications such as phenytoin and carbamazepine\n\nHeart medications like verapamil or propranolol\n\nDiuretics, especially furosemide\n\nOral contraceptives\n\nSmoking (which can reduce drug effectiveness)\n\nAnti-flu drugs like oseltamivir\n\nThese interactions can either raise the levels of theophylline in the blood or reduce its effectiveness, so regular monitoring and dose adjustment may be required.\n\nConclusion\nSLO THEO Tablets, containing etophylline 231 mg and theophylline 69 mg, offer a reliable solution for those suffering from obstructive airway diseases like asthma and COPD. The synergistic action of these bronchodilators helps in easing breathing, reducing wheezing, and preventing respiratory distress. Though effective, it is essential to take these tablets under medical supervision, especially if you are on other medications or have pre-existing health conditions.\n\nAlways follow your physician’s advice regarding dosage, frequency, and duration of treatment to ensure optimal therapeutic outcomes and minimize any potential risks associated with the use of etophylline and theophylline tablets.", "price": 90.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2149, "imageuri": "https://productimages.withfloats.com/actual/6880c5d95b53b8e224cf86f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/6880c5d95b53b8e224cf86f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-23T11:21:45.632Z", "updatedon": "2025-12-09T06:33:57.85Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slo-theo-tablets/2149", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "etophylline and theophylline tablets", "category": "ASTHMARANGE", "tags": [ "etophylline and theophylline tablets", "etophylline and theophylline tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "68723260f860f0528a938842", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "amisulpride tablet", "description": "AMIPULSIDE CR 400 is a prescription-based, controlled-release formulation of Amisulpride 400 mg, developed to offer sustained therapeutic effects with once-daily dosing. Manufactured to high quality standards, this medication plays a vital role in the management of both acute and chronic schizophrenic disorders. It belongs to the class of atypical antipsychotics and works by regulating the activity of certain neurotransmitters in the brain, primarily dopamine. This helps control symptoms like hallucinations, delusions, disorganized thinking, and social withdrawal associated with schizophrenia.\n\nWhat is AMIPULSIDE CR 400?\nAMIPULSIDE CR 400 contains Amisulpride, a selective dopamine D2/D3 receptor antagonist. It is primarily used in the treatment of schizophrenia, particularly effective in managing both positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., emotional withdrawal, apathy). The controlled-release (CR) formulation allows for steady absorption and action, improving patient compliance and reducing fluctuations in symptom control.\n\nThis medication is designed for the treatment of acute and chronic schizophrenic disorders and is often used as part of a comprehensive psychiatric care plan, including counseling and behavioral therapy.\n\nUses of AMIPULSIDE CR 400\nManagement of acute episodes of schizophrenia\n\nLong-term maintenance therapy for chronic schizophrenic disorders\n\nEffective in treating positive symptoms (e.g., hallucinations, paranoia)\n\nBeneficial in alleviating negative symptoms (e.g., lack of motivation, social withdrawal)\n\nSide Effects of AMIPULSIDE CR 400\nLike all medications, AMIPULSIDE CR 400 may cause side effects in some patients. Common side effects include:\n\nInsomnia or drowsiness\n\nWeight gain\n\nConstipation\n\nAnxiety\n\nIncreased prolactin levels (can lead to breast tenderness or menstrual changes)\n\nTremors or stiffness (extrapyramidal symptoms)\n\nSerious but rare side effects may include:\n\nNeuroleptic malignant syndrome (fever, muscle rigidity, confusion)\n\nIrregular heart rhythms\n\nSeizures\n\nSeek immediate medical help if you experience chest pain, severe dizziness, or signs of an allergic reaction.\n\nPrecautions Before Using AMIPULSIDE CR 400\nBefore starting treatment with AMIPULSIDE CR 400, inform your doctor if:\n\nYou have a history of heart disease or irregular heart rhythms\n\nYou suffer from kidney or liver dysfunction\n\nYou are pregnant, planning pregnancy, or breastfeeding\n\nYou have Parkinson’s disease\n\nYou have low potassium or magnesium levels in your blood\n\nAvoid alcohol and other central nervous system depressants while taking this medication, as they may increase drowsiness or impair alertness.\n\nDrug Interactions\nAmisulpride can interact with a variety of medications, which may enhance or diminish its therapeutic effects or increase the risk of adverse events.\n\nWhat Drugs Interact with AMIPULSIDE CR 400?\nAntiarrhythmic drugs (e.g., quinidine, amiodarone): May increase the risk of heart rhythm abnormalities\n\nCNS depressants (e.g., benzodiazepines, opioids): Increase sedation and respiratory depression risk\n\nLevodopa and dopamine agonists: Can counteract the effect of Amisulpride\n\nSSRIs (e.g., fluoxetine, paroxetine): May increase the plasma levels of Amisulpride\n\nDrugs that prolong QT interval (e.g., erythromycin, haloperidol): May raise the risk of cardiac arrhythmias\n\nDiuretics: May alter electrolyte balance, increasing risk of heart rhythm disturbances\n\nAlways disclose all medications, supplements, or herbal products you are taking to your healthcare provider before starting AMIPULSIDE CR 400.\n\nConclusion\n\nAMIPULSIDE CR 400 (Amisulpride 400 mg CR Tablet) is a clinically effective medication for individuals suffering from schizophrenia, offering reliable symptom control through its controlled-release formulation. Its ability to treat both the acute and chronic phases of the disorder makes it a cornerstone in psychiatric management. Regular monitoring and adherence to prescribed guidelines ensure optimal results and improved quality of life for patients.", "price": 557.0, "discountamount": 167.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2145, "imageuri": "https://productimages.withfloats.com/actual/687232764d22e47aa874e361.png", "tileimageuri": "https://productimages.withfloats.com/tile/687232764d22e47aa874e361.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-12T10:01:04.938Z", "updatedon": "2025-12-02T07:12:40.118Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/amisulpride-tablet/2145", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "NEUROLOGY RANGE", "tags": [ "Amisulpride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }